Larson Financial Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$5 | – | 3302 |
|
|
2025
Q1 | $5 | Hold |
1
| – | – | ﹤0.01% | 3057 |
|
|
2024
Q4 | $8 | Hold |
1
| – | – | ﹤0.01% | 2758 |
|
|
2024
Q3 | $12 | Hold |
1
| – | – | ﹤0.01% | 2684 |
|
|
2024
Q2 | $24 | Hold |
1
| – | – | ﹤0.01% | 2403 |
|
|
2024
Q1 | $31 | Hold |
1
| – | – | ﹤0.01% | 1763 |
|
|
2023
Q4 | $33 | Hold |
1
| – | – | ﹤0.01% | 1767 |
|
|
2023
Q3 | $73 | Hold |
1
| – | – | ﹤0.01% | 1672 |
|
|
2023
Q2 | $79 | Hold |
1
| – | – | ﹤0.01% | 1535 |
|
|
2023
Q1 | $76 | Hold |
1
| – | – | ﹤0.01% | 1509 |
|
|
2022
Q4 | $166 | Hold |
1
| – | – | ﹤0.01% | 1435 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1301 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1194 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1046 |
|
|
2021
Q4 | $0 | Sell |
1
-1
| -50% | -$236 | ﹤0.01% | 1076 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 882 |
|
|
2021
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 752 |
|
|
2021
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 748 |
|
|
2020
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 675 |
|
|
2020
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 637 |
|
|
2020
Q2 | $1K | Buy |
+2
| New | +$1.51K | ﹤0.01% | 595 |
|
Other funds holding BLUE
Larson Financial Group's BLUE Position: Q2 2025 in Review
Larson Financial Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 1 share — an estimated $5 sold.
Larson Financial Group first reported a position in BLUE in Q2 2020 and held it in 20 quarters. The position peaked at $1K in Q2 2021. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Larson Financial Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Larson Financial Group sold 1 bluebird bio share in Q2 2025, an estimated $5.
- Larson Financial Group first reported a position in bluebird bio in Q2 2020 and held it in 20 quarters.
- Larson Financial Group's bluebird bio position peaked at $1K in Q2 2021.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.